News
Medtronic has received FDA 510(k) clearance for its MiniMed Connect device, which allows users of Medtronic's continuous glucose monitor (CGM) and insulin pump to view data from those devices on their smartphone.
Ranya Habash, MD, a noted ophthalmologist and CMO of Everbridge, says the most innovative mHealth technology should fly under the radar (and that won't include robots).
Google has begun to test the first app that will be used in the wider rollout of its Google Baseline study, called the Study Kit app, according to a new report from TechCrunch.
Seattle-based Carena, which offers a video visit service for health systems, has raised $13.
FDA clearances for digital health devices are on track to triple by 2018, according to new research from Accenture, as digital health offerings drive more than $100 billion in savings over that same time period.
Jawbone UP2
Just three months after Apple pulled a number of wristworn fitness tracking devices from its stores, including Jawbone UP24 and Nike FuelBand SE, Jawbone Senior Product Manager Jason Donahue revealed that the company's devices would return to the Apple Store in the coming months during a presentation he gave in Japan, according to local reports in that country, and as explained in a report from Apple Insider.
While Teladoc has been pulling in a lot of press lately with its IPO news, competitor American Well has been busy too, securing an eight-figure investment from Israeli pharmaceutical giant Teva, according to a recent report in Israeli publication Globes.
New York City and Austin, Texas-based Informed Data Systems has raised $8 million for its One Drop mobile diabetes management platform.
The wearable device market grew in Q1 for the eighth consecutive year, according to a report from research firm IDC.
Last week, JAMA Internal Medicine published a two-page research letter by the Rand Corporation that played into a national conversation about the efficacy of telemedicine -- specifically Teladoc, a company which is both about to IPO and embroiled in a potentially precedent-setting legal battle with its home state of Texas over whether the Texas Medical Board has the right to regulate the practice of telemedicine.